Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.65B | 2.60B | 2.70B | 2.11B | 2.22B | 884.57M |
Gross Profit | 1.18B | 2.66B | 848.40M | 2.08B | 2.13B | 7.83M |
EBITDA | 224.20M | 314.60M | 393.90M | -370.20M | 4.64B | 160.10M |
Net Income | 169.70M | 199.90M | 354.80M | -386.00M | 58.10M | 143.80M |
Balance Sheet | ||||||
Total Assets | 12.36B | 12.52B | 12.87B | 11.04B | 10.62B | 3.54B |
Cash, Cash Equivalents and Short-Term Investments | 5.66B | 6.03B | 6.10B | 4.33B | 2.08B | 525.99M |
Total Debt | 706.40M | 639.10M | 786.20M | 778.00M | 816.70M | 114.27M |
Total Liabilities | 10.25B | 10.59B | 10.34B | 8.95B | 8.12B | 1.97B |
Stockholders Equity | 2.11B | 1.94B | 2.51B | 2.07B | 2.50B | 1.56B |
Cash Flow | ||||||
Free Cash Flow | 135.10M | 74.70M | 581.30M | 292.50M | 1.60M | 73.36M |
Operating Cash Flow | 135.10M | 74.70M | 581.30M | 293.30M | 1.60M | 73.36M |
Investing Cash Flow | 970.60M | 343.60M | -332.20M | -1.30B | 208.60M | 6.11M |
Financing Cash Flow | -906.50M | -625.00M | -61.50M | -23.70M | 24.30M | -19.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | $11.64B | 6.31 | 18.75% | 0.65% | 23.19% | -22.42% | |
82 Outperform | $2.40B | 6.40 | 15.86% | ― | 28.86% | -11.22% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $12.70B | 16.72 | 7.07% | 1.90% | 1.53% | -10.27% | |
64 Neutral | $2.22B | 21.20 | 4.82% | ― | -4.56% | -55.48% | |
61 Neutral | $429.19M | 11.46 | 5.82% | ― | 2.18% | -41.11% | |
49 Neutral | $20.72M | ― | -58.30% | ― | ― | 78.09% |
On September 3, 2025, SiriusPoint Ltd. announced the appointment of Martin Hudson to its board of directors, effective September 1, 2025. With over 40 years of experience in the (re)insurance industry, Hudson’s leadership spans underwriting, risk management, and executive management across global markets. His appointment is expected to strengthen SiriusPoint’s business and support its growth strategies, delivering long-term value for shareholders and stakeholders.
The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On July 30, 2025, SiriusPoint Ltd. adopted an Executive Severance Plan, effective August 1, 2025, to provide severance payments and benefits to eligible employees in the event of certain employment terminations. The plan outlines specific benefits for executives and other eligible employees, including lump sum payments, full vesting of cash bonuses, and medical benefits. Enhanced benefits are provided if a termination occurs within a year following a change in control, defined by specific criteria such as acquisition of voting securities or board changes.
The most recent analyst rating on (SPNT) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On August 4, 2025, SiriusPoint Ltd. reported its second quarter 2025 financial results, highlighting a significant improvement in its core combined ratio to 89.5%, a 3.8-point improvement from the previous year. The company achieved an 83% year-over-year growth in underwriting income to $68 million and a 10% growth in gross premiums written for its core business. The second quarter return on equity was 12.7%, with underlying earnings per share increasing by 120% from the prior year. SiriusPoint also announced a quarterly cash dividend of $0.50 per share on its Series B preference shares, approved on July 30, 2025. The company was recognized as Program Insurer of the Year in the US, achieved record employee engagement scores, and added new executive leadership members, reinforcing its strategic growth and positioning in the industry.
The most recent analyst rating on (SPNT) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.